FDA approves Pfizer’s new nasal spray treatment for migraines
The U.S. Food and Drug Administration has authorized Pfizer’s most recent drug on the migraine
The U.S. Food and Drug Administration has authorized Pfizer’s most recent drug on the migraine
The FDA has approved omaveloxolone (Skyclarys), an agent developed by Reata Pharmaceuticals for the treatment
Washington — U.S. wellness regulators on Tuesday approved the initially gene treatment for hemophilia, a $3.5
By JEFFREY COLLINS and JAMES POLLARD – Involved Press COLUMBIA, S.C. (AP) — The South